Scopus BioPharma Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q3 2020 to Q2 2023

Taxonomy & unit: us-gaap: USD/shares
Description: The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary: Scopus BioPharma Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2020 to Q2 2023.
Scopus BioPharma Inc. Earnings Per Share, Basic for the quarter ending June 30, 2023 was -0.07 USD/shares, a 56.3% increase year-over-year.
Scopus BioPharma Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2023 was -0.32 USD/shares, a 57.3% increase year-over-year.
Scopus BioPharma Inc. annual Earnings Per Share, Basic for 2022 was -0.55 USD/shares, a 64.7% increase from 2021.
Scopus BioPharma Inc. annual Earnings Per Share, Basic for 2021 was -1.56 USD/shares, a 92.6% decline from 2020.

Earnings Per Share, Basic, Trailing 12 Months (USD/shares)

Earnings Per Share, Basic, Quarterly (USD/shares)

Earnings Per Share, Basic, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2023	$0	$0	+$0.09	+56.3%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-11
Q1 2023	$0	$0	+$0.14	+63.6%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-12
Q4 2022	-$1	$0	+$0.21	+72.4%	Oct 1, 2022	Dec 31, 2022	10-K	2023-04-14
Q3 2022	-$1	$0	$0	-12.5%	Jul 1, 2022	Sep 30, 2022	10-Q	2022-11-21
Q2 2022	-$1	$0	+$0.81	+83.5%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-11
Q1 2022	-$2	$0	$0	0%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-12
Q4 2021	-$2	$0			Oct 1, 2021	Dec 31, 2021	10-K	2023-04-14
Q3 2021		$0	$0	0%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-21
Q2 2021		-$1			Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-15
Q1 2021		$0			Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-19
Q3 2020		$0			Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.